Literature DB >> 24570175

Chemical labyrinthectomy for the worse ear of adult Nigerians with bilateral Meniere's disease: preliminary report of treatment outcomes.

A D Olusesi1, S B Hassan, Y Oyeyipo, U C Ukwuije, O Oyeniran.   

Abstract

The objective of this study was to assess the effectiveness of variable titration, low-dose intratympanic gentamycin (ITG) into the worse affected ear of patients with bilateral Meniere's disease (MD). It is a prospective analytic case series conducted in a tertiary care referral hospital in a developing economy and a tertiary care otologic private ENT clinic. Patients with MD who failed or are intolerant to medical treatment were recruited based on the criteria of definite MD and bilateral ear involvement. 0.75 cc of low-dose (40 mg/ml) buffered gentamycin was injected into the worse affected ear and patients followed up every 2 months, and the regime repeated only if subjective vertigo persists. The patient's age, sex, duration of MD symptom, ear first affected, ear selected for ITG, pure tone threshold at each visit, duration of caloric response (in seconds) for the injected ear, status of tinnitus in both ipsilateral (injected) and contralateral ears, total number of injections before last follow-up, and time since last follow-up are entered into the study protocol and analyzed. Nine patients with a mean age of 45 years and mean duration of symptoms of 59 months were treated. The mean total number of injections was 2.8 with a mean follow-up period of 34 months. Three cases showed drop in pure tone average threshold (2.5-7.5 dB) while an increase in threshold was noted in six cases (2.5-5 dB). All cases demonstrated decrease in duration of response to iced water caloric stimulation in ipsilateral ear, and 4/9 of contralateral ear. The variable titration method using low-dose intratympanic gentamycin directed at worse ear of adult Nigerians with bilateral Meniere's disease appears to be highly effective. More studies are needed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24570175     DOI: 10.1007/s00405-014-2947-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  24 in total

1.  Meniere's disease: prevalence of contralateral ear involvement.

Authors:  John W House; Joni K Doherty; Laurel M Fisher; M Jennifer Derebery; Karen I Berliner
Journal:  Otol Neurotol       Date:  2006-04       Impact factor: 2.311

2.  Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis.

Authors:  Stanley H Chia; Anthony C Gamst; John P Anderson; Jeffrey P Harris
Journal:  Otol Neurotol       Date:  2004-07       Impact factor: 2.311

3.  Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections.

Authors:  Raquel Manrique-Huarte; Francisco Guillén-Grima; Nicolas Perez-Fernandez
Journal:  Otol Neurotol       Date:  2011-04       Impact factor: 2.311

Review 4.  Intratympanic gentamicin for Ménière's disease or syndrome.

Authors:  Bas Pullens; Peter Paul van Benthem
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

5.  Prognosis of Menière's disease by conservative treatment: retrospective study on the time course of the disease.

Authors:  K Tokumasu; A Fujino; S Yoshio; I Hoshino
Journal:  Acta Otolaryngol Suppl       Date:  1995

6.  Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.

Authors:  Herbert Silverstein; Jack Wazen; Mark J Van Ess; Julie Daugherty; Yadiel A Alameda
Journal:  Otolaryngol Head Neck Surg       Date:  2010-04       Impact factor: 3.497

7.  Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.

Authors:  Iee Ching Wu; Lloyd B Minor
Journal:  Laryngoscope       Date:  2003-05       Impact factor: 3.325

Review 8.  Outcomes of intratympanic gentamicin injection to treat Ménière's disease.

Authors:  Leh-Kiong Huon; Te-Yung Fang; Pa-Chun Wang
Journal:  Otol Neurotol       Date:  2012-07       Impact factor: 2.311

Review 9.  Clinical hints and precipitating factors in patients suffering from Meniere's disease.

Authors:  Steven D Rauch
Journal:  Otolaryngol Clin North Am       Date:  2010-10       Impact factor: 3.346

10.  High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.

Authors:  Li-Chun Hsieh; Hung-Ching Lin; Hsun-Tien Tsai; Yi-Ching Ko; Min-Tsan Shu; Li-Hui Lin
Journal:  Acta Otolaryngol       Date:  2009-12       Impact factor: 1.494

View more
  1 in total

1.  10 years of Vertigo Clinic at National Hospital Abuja, Nigeria: what have we learned?

Authors:  Abiodun D Olusesi; J Abubakar
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-09       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.